232 related articles for article (PubMed ID: 3797115)
1. Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure.
Hallman M; Merritt TA; Pohjavuori M; Gluck L
Pediatr Res; 1986 Dec; 20(12):1228-35. PubMed ID: 3797115
[TBL] [Abstract][Full Text] [Related]
2. Endobronchial surface active phospholipids in various pulmonary diseases.
Hallman M; Arjomaa P; Tahvanainen J; Lachmann B; Spragg R
Eur J Respir Dis Suppl; 1985; 142():37-47. PubMed ID: 3860395
[TBL] [Abstract][Full Text] [Related]
3. Absence of phosphatidylglycerol (PG) in respiratory distress syndrome in the newborn. Study of the minor surfactant phospholipids in newborns.
Hallman M; Feldman BH; Kirkpatrick E; Gluck L
Pediatr Res; 1977 Jun; 11(6):714-20. PubMed ID: 577302
[TBL] [Abstract][Full Text] [Related]
4. Endogenous surfactant metabolism in newborn infants with and without respiratory failure.
Bohlin K; Merchak A; Spence K; Patterson BW; Hamvas A
Pediatr Res; 2003 Aug; 54(2):185-91. PubMed ID: 12736380
[TBL] [Abstract][Full Text] [Related]
5. [The lung phospholipid content in newborn infants with idiopathic respiratory distress syndrome in relation to lung histology and survival time (author's transl)].
Krepler R; Davidovits A; Eckerstorfer R; Denk H
Wien Klin Wochenschr; 1976 Sep; 88(17):554-7. PubMed ID: 1036640
[TBL] [Abstract][Full Text] [Related]
6. Prenatal dexamethasone and exogenous surfactant therapy: surface activity and surfactant components in airway specimens.
Kari MA; Akino T; Hallman M
Pediatr Res; 1995 Nov; 38(5):676-84. PubMed ID: 8552433
[TBL] [Abstract][Full Text] [Related]
7. Surfactant protein A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid. Correlation with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants.
Hallman M; Merritt TA; Akino T; Bry K
Am Rev Respir Dis; 1991 Dec; 144(6):1376-84. PubMed ID: 1741552
[TBL] [Abstract][Full Text] [Related]
8. Surfactant phosphatidylcholine half-life and pool size measurements in premature baboons developing bronchopulmonary dysplasia.
Janssen DJ; Carnielli VP; Cogo PE; Seidner SR; Luijendijk IH; Wattimena JL; Jobe AH; Zimmermann LJ
Pediatr Res; 2002 Nov; 52(5):724-9. PubMed ID: 12409520
[TBL] [Abstract][Full Text] [Related]
9. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
[TBL] [Abstract][Full Text] [Related]
10. Phospholipids in tracheal effluent from infants with severe respiratory distress syndrome.
Bose CL; Richardson P; Wood B; Gonzalez F; King J
Am J Perinatol; 1984 Apr; 1(3):208-13. PubMed ID: 6549258
[TBL] [Abstract][Full Text] [Related]
11. Distribution of a second dose of exogenous surfactant in rabbits with severe respiratory failure.
Plötz FB; Stevens H; Heikamp A; Oetomo SB
Pediatr Res; 1995 Apr; 37(4 Pt 1):476-81. PubMed ID: 7596688
[TBL] [Abstract][Full Text] [Related]
12. [The appearance of surface-active phospholipids of the surfactant-system of the lung during ontogenetic development of humans (author's transl)].
Winsel K; Lachmann B; Bergmann KC; Wauer R; Bauke G
Z Erkr Atmungsorgane; 1976 Mar; 144(3):220-30. PubMed ID: 989205
[TBL] [Abstract][Full Text] [Related]
13. Role of myoinositol in regulation of surfactant phospholipids in the newborn.
Hallman M; Saugstad OD; Porreco RP; Epstein BL; Gluck L
Early Hum Dev; 1985 Jan; 10(3-4):245-54. PubMed ID: 3838720
[TBL] [Abstract][Full Text] [Related]
14. Positive end-expiratory pressure during KL4 surfactant instillation enhances intrapulmonary distribution in a simian model of respiratory distress syndrome.
Merritt TA; Kheiter A; Cochrane CG
Pediatr Res; 1995 Aug; 38(2):211-7. PubMed ID: 7478818
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous measurement of phosphatidylglycerol and disaturated-phosphatidylcholine palmitate kinetics from alveolar surfactant. Study in infants with stable isotope tracer, coupled with isotope ratio mass spectrometry.
Vedovelli L; Baritussio A; Carnielli VP; Simonato M; Giusti P; Cogo PE
J Mass Spectrom; 2011 Oct; 46(10):986-92. PubMed ID: 22012664
[TBL] [Abstract][Full Text] [Related]
16. Improving the prediction of surfactant deficiency in very low-birthweight infants with respiratory distress.
Harker LC; Merritt TA; Edwards DK
J Perinatol; 1992 Jun; 12(2):129-33. PubMed ID: 1522430
[TBL] [Abstract][Full Text] [Related]
17. Exogenous surfactant kinetics in infant respiratory distress syndrome: A novel method with stable isotopes.
Torresin M; Zimmermann LJ; Cogo PE; Cavicchioli P; Badon T; Giordano G; Zacchello F; Sauer PJ; Carnielli VP
Am J Respir Crit Care Med; 2000 May; 161(5):1584-9. PubMed ID: 10806159
[TBL] [Abstract][Full Text] [Related]
18. The fate of exogenous surfactant in neonates with respiratory distress syndrome.
Hallman M; Merritt TA; Bry K
Clin Pharmacokinet; 1994 Mar; 26(3):215-32. PubMed ID: 8194284
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary surfactant kinetics of the newborn infant: novel insights from studies with stable isotopes.
Carnielli VP; Zimmermann LJ; Hamvas A; Cogo PE
J Perinatol; 2009 May; 29 Suppl 2():S29-37. PubMed ID: 19399007
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of bovine surfactant in neonatal respiratory distress syndrome.
Griese M; Dietrich P; Reinhardt D
Am J Respir Crit Care Med; 1995 Sep; 152(3):1050-4. PubMed ID: 7663782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]